AKT1 and melanoma: Delphinidin prevented VEGF-induced proliferation and activation of ERK 1/2 and p38 MAP kinase, a mechanism susceptible to PI3/AKT inhibitors, to diminish B16-F10 melanoma cell xenograft-induced tumor growth [103].